CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹11 Cr | ₹-14 Cr | ₹12 Cr | ₹2.83 Cr | ₹-4.48 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CONCORD BIOTECH ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹11 Cr |
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹2.83 Cr |
| Mar2022 | ₹-4.48 Cr |
How is Net Cash Inflow / Outflow of CONCORD BIOTECH Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹11 Cr | Positive | |
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹12 Cr | 311.12 | |
| Mar2023 | ₹2.83 Cr | Positive | |
| Mar2022 | ₹-4.48 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹15,626.2 Cr | 0.7% | -6.7% | -11.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 0.7% |
-6.7% |
-11.2% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses